MST1/2 Hippo Kinases Direct Macrophage Death in Infection and Inflammation

Study Background and Research Question

The Hippo signaling pathway, conserved across eukaryotes, is a central regulator of organ development, cell proliferation, differentiation, and cell cycle control. At its core are the mammalian STE20-like kinases MST1 and MST2 (MST1/2), traditionally recognized for their tumor-suppressive functions and roles in tissue homeostasis. However, emerging evidence suggests that Hippo kinases also influence immune cell fate, particularly in macrophages—a key phagocytic cell type orchestrating host defense and inflammatory responses. Notably, organisms deficient in MST1/2 exhibit increased susceptibility to infection, hinting at an immunomodulatory role. The reference study (Quagliato et al., 2025) directly interrogates how MST1/2 integrate signals from pathogens and inflammatory mediators to coordinate macrophage cell death, illuminating mechanistic intersections between apoptosis, pyroptosis, and innate immunity.

Key Innovation from the Reference Study

The innovation of this work lies in identifying MST1/2 cleavage as a central node by which macrophages interpret and execute programmed cell death decisions under diverse stressors. Specifically, the study demonstrates that MST1/2 are proteolytically activated by both sterile inflammatory triggers (such as ATP and nigericin) and infectious agents (including Legionella pneumophila and Yersinia pseudotuberculosis). This cleavage event enables MST1/2 to direct the cell toward apoptosis, especially when canonical pyroptosis pathways (mediated by NLRP3 inflammasome and gasdermin D, or GSDMD) are absent or suppressed. The finding that GSDMD knockout (KO) macrophages switch from pyroptosis to MST1/2-driven apoptosis in response to Pseudomonas aeruginosa infection underscores a previously unappreciated flexibility and redundancy in cell death networks. Thus, MST1/2 function as a molecular hub integrating pathogen- and damage-derived signals to dictate macrophage fate (Quagliato et al., 2025).

Methods and Experimental Design Insights

The study employs a combination of genetic, biochemical, and cell biological approaches to dissect the interplay between MST1/2 signaling and macrophage death modalities. Key elements of the experimental design include:

• Use of wild-type (WT) and MST1/2 double knockout (DKO) macrophages to define kinase-specific effects.
• Genetic ablation of GSDMD to parse the contributions of pyroptotic pathways.
• Exposure of cells to sterile inflammatory triggers (ATP, nigericin) versus live bacterial pathogens, distinguishing between infectious and non-infectious stimuli.
• Immunoblotting for full-length and cleaved MST1/2 to monitor proteolytic processing.
• Assessment of downstream apoptotic and pyroptotic markers, including caspase activation, gasdermin cleavage, and PARP1 fragmentation.
• Functional assays to quantify apoptosis and pyroptosis rates under different genetic and pharmacological conditions.

These approaches allow rigorous delineation of cell death mechanisms and the contextual roles of MST1/2 under both physiological and pathological conditions.

Protocol Parameters

• Macrophage genotype selection: Use WT, MST1/2 DKO, and GSDMD KO backgrounds to unmask pathway-specific effects on cell death.
• Inflammatory trigger selection: Apply ATP (5 mM, 30–60 min) or nigericin (10 µM, 30–60 min) to model sterile inflammation; infect with L. pneumophila, Y. pseudotuberculosis, or P. aeruginosa for pathogen-driven responses.
• Detection of apoptosis: Employ DNA fragmentation assays (e.g., TUNEL), immunoblotting for PARP1/caspase-3 cleavage, and morphological criteria (chromatin condensation).
• Pyroptosis readouts: Monitor GSDMD cleavage, LDH release, and propidium iodide uptake.
• Pharmacological inhibition: Use pan-caspase or caspase-specific inhibitors as controls to verify caspase dependence of MST1/2 cleavage and downstream events.

Core Findings and Why They Matter

The central findings of Quagliato et al. are as follows:

• MST1/2 are cleaved in response to both sterile (ATP/nigericin) and infectious (L. pneumophila, Y. pseudotuberculosis) challenges, independent of NLRP3 or GSDMD activation status.
• Cleaved MST1/2 (N-terminal kinase fragments) exhibit enhanced pro-apoptotic activity, driving macrophage apoptosis when pyroptosis is genetically or functionally ablated.
• During P. aeruginosa infection, WT macrophages favor GSDMD-dependent pyroptosis, but GSDMD KO cells shift to apoptosis via MST1/2 cleavage, highlighting a compensatory network.
• MST1/2 DKO macrophages are resistant to both apoptotic stimuli and proapoptotic drugs, while naive T cells lacking MST1 remain apoptosis-sensitive, indicating cell type-specific regulation.

These discoveries elucidate how innate immune sensors, inflammasome effectors, and Hippo kinases converge to regulate macrophage death—a process critical for pathogen containment, inflammation resolution, and tissue integrity. The context-dependent choice between apoptosis and pyroptosis may also shape subsequent immune responses and tissue remodeling.

Comparison with Existing Internal Articles

Recent internal reviews and scenario analyses provide complementary perspectives on apoptosis detection strategies. For example, the article "One-step TUNEL FITC Apoptosis Detection Kit: Atomic Benchmarking" details the mechanistic rationale and validation of FITC-labeled dUTP incorporation for sensitive DNA fragmentation assays. This approach is highly relevant for quantifying apoptosis in both tissue sections and cultured cells, as performed in the MST1/2 study. Another relevant resource, "Reliable Apoptosis Detection: Scenario-Based Insights", discusses how robust TUNEL-based protocols can enhance reproducibility and confidence in cell death quantification, echoing the methodological rigor of the reference paper. These internal articles reinforce the translational importance of selecting validated apoptosis detection platforms, particularly when dissecting complex death pathways in primary immune cells and disease models.

Limitations and Transferability

While the study by Quagliato et al. provides compelling mechanistic insights, several limitations should be considered. Most experiments are conducted in murine macrophage models, and the generalizability to human immune cells or other cell types (e.g., T cells, cancer cells) may require further validation. The interplay between MST1/2 and other death effectors (such as GSDME or necroptotic mediators) is not explored in depth, limiting insight into broader cell death networks. Additionally, the experimental focus is on acute responses to specific pathogens or stimuli; chronic inflammatory or tumor microenvironments may engage distinct regulatory axes. Despite these caveats, the demonstration that MST1/2 cleavage governs the choice between apoptosis and pyroptosis in macrophages provides a conceptual framework for studying programmed cell death under a spectrum of pathological conditions.

Research Support Resources

Researchers aiming to extend these findings or quantitatively monitor apoptosis in tissue sections and cultured cells can leverage validated DNA fragmentation assays. The One-step TUNEL FITC Apoptosis Detection Kit (SKU K1133) from APExBIO offers a streamlined, sensitive workflow for detecting FITC-labeled dUTP incorporation at DNA 3'-OH termini—an established hallmark of apoptosis. This kit is compatible with diverse sample types and is suitable for supporting workflows similar to those described in MST1/2-focused cell death studies. Proper integration of such quantitative assays can facilitate rigorous analysis of apoptotic processes in both research and translational settings.